跳至主要内容
临床试验/NCT05821400
NCT05821400招募中不适用

Cognitive Changes in Mild Cognitive Impairment Without Orthostatic Hypotension

Fujian Medical University Union Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Changes in Montreal Cognitive Assessment (MoCA) scores after 3 months.

研究概览

简要总结

Background: In recent years, the changes of cognitive function in mild cognitive impairment have attracted attention.

Methods/design: We will follow up at 3. The primary outcome will be the measurement of cognitive function using neuropsychological assessment scales such as MOCA, MMSE, etc... Minor variables will be included plasma biomarkers (Aβ, Tau, GFAP, etc.), multimodal brain electrophysiology (P300, VP300, heart rate variability, etc.), and neuroimaging indicators (NODDI).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically diagnosed mild cognitive impairment

排除标准

  • Patients with orthostatic hypotension
  • Patients with other neurological disorders.
  • Pregnant or lactating women.

结局指标

主要结局

Changes in Montreal Cognitive Assessment (MoCA) scores after 3 months.

时间窗: Participants will be followed up for 3 months after baseline.

The MOCA scale scores range from 0 to 30, with higher scores indicating better cognition

次要结局

  • Changes in Blood pressure (mmHg) after 3 months.(Participants will be followed up for 3 months after baseline.)
  • Changes in Plasma tau levels after 3 months.(Participants will be followed up for 3 months after baseline.)
  • Changes in Plasma amyloid protein levels after 3 months.(Participants will be followed up for 3 months after baseline.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验